
Quantitative Drug Safety and Benefit Risk Evaluation
749,-

Real-World Evidence in Drug Development and Evaluation
729,-

Multiple Testing Problems in Pharmaceutical Statistics
679,-

Design and Analysis of Bioavailability and Bioequivalence Studies
679,-

Real-World Evidence in a Patient-Centric Digital Era
648,-

Frailty Models in Survival Analysis
669,-

Confidence Intervals for Discrete Data in Clinical Research
668,-

Adaptive Design Methods in Clinical Trials
679,-

Advanced Statistics in Regulatory Critical Clinical Initiatives
728,-

Estimands, Estimators and Sensitivity Analysis in Clinical Trials
669,-

Quantitative Drug Safety and Benefit Risk Evaluation
749,-

Real-World Evidence in Drug Development and Evaluation
729,-

Multiple Testing Problems in Pharmaceutical Statistics
679,-

Design and Analysis of Bioavailability and Bioequivalence Studies
679,-

Real-World Evidence in a Patient-Centric Digital Era
648,-

Frailty Models in Survival Analysis
669,-

Confidence Intervals for Discrete Data in Clinical Research
668,-

Adaptive Design Methods in Clinical Trials
679,-

Advanced Statistics in Regulatory Critical Clinical Initiatives
728,-

Estimands, Estimators and Sensitivity Analysis in Clinical Trials
669,-